✦ LIBER ✦

FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients

✍ Scribed by Fasching, Peter A; Jud, Sebastian M; Hauschild, Maik; Kümmel, Sherko; Schütte, Martin; Warm, Matthias; Hanf, Volker; Grab, Dieter; Krocker, Jutta; Stickeler, Elmar; Kreienberg, Rolf; Müller, Thomas; Kühn, Thorsten; Wolf, Christopher; Kahlert, Steffen; Paepke, Stefan; Berghorn, Michael; Muth, Mathias; Baier, Monika; Wackwitz, Birgit; Schulz-Wendtland, Rüdiger; Beckmann, Matthias W; Lux, Michael P

Book ID: 121535421
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 251 KB
Volume: 14
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-14-66

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Randomized Study of Neoadjuvant

Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor–Positive Breast Cancer

✍ Esteva, F.J. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Randomized Phase II Trial of Letrozole a

Randomized Phase II Trial of Letrozole and Letrozole Plus Low-Dose Metronomic Oral Cyclophosphamide as Primary Systemic Treatment in Elderly Breast Cancer Patients

✍ Burstein, H.J. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 111 KB

The Protective Effect of Zoledronic Acid

The Protective Effect of Zoledronic Acid on Bone Loss in Postmenopausal Women with Early Breast Cancer Treated with Sequential Tamoxifen and Letrozole: A Prospective, Randomized, Phase II Trial

✍ Safra, Tamar; Bernstein-Molho, Rinat; Greenberg, Julia; Pelles-Avraham, Sharon; 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 317 KB

Phase II trial with letrozole to maximum

Phase II trial with letrozole to maximum response as primary systemic therapy in postmenopausal patients with ER/PgR[+] operable breast cancer

✍ Antonio Llombart-Cussac; Ángel Guerrero; Antonio Galán; Vicente Carañana; Elvira 📂 Article 📅 2012 🏛 Springer Milan 🌐 Spanish ⚖ 355 KB

Phase II trial with letrozole (2.5 mg) t

Phase II trial with letrozole (2.5 mg) to maximal response as neoadjuvant endocrine therapy in postmenopausal patients with ER/PgR[+] operable breast cancer

✍ A. Llombart; Galán; C. Fuster; E. Buch; V. Carañana; A. Rodriguez-Lescure; C. Vá 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 131 KB

P128 Phase II trial with letrozole (2.8

P128 Phase II trial with letrozole (2.8 mg) to maximal response as neoadjuvant endocrine therapy in postmenopausal patients with ER/PgR[+] operable breast cancer

✍ A. Lombart-Cussac; A. Galán; C. Fuster Diana; E. Buch; V. Carañana; A. Rodriguez 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB